Initiator Pharma A/S (STO:INIT)
Sweden · Delayed Price · Currency is SEK 2.490
-0.040 (-1.58%)
Aug 13, 2026, 5:29 PM CET
Initiator Pharma Market Cap
Initiator Pharma has a market cap or net worth of 170.45 million as of August 13, 2026. Its market cap has decreased by -28.65% in one year.
Market Cap
170.45M
Enterprise Value
152.42M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.49
ChartMarket Cap Chart
Since March 16, 2017, Initiator Pharma's market cap has increased from 50.37M to 170.45M, an increase of 238.41%. That is a compound annual growth rate of 13.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 170.45M | -15.88% |
| Dec 30, 2025 | 202.62M | -47.31% |
| Dec 30, 2024 | 384.53M | -20.69% |
| Dec 29, 2023 | 484.84M | 52.80% |
| Dec 30, 2022 | 317.31M | -10.94% |
| Dec 30, 2021 | 356.31M | 167.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| IRLAB Therapeutics AB | 224.56M |
| Xbrane Biopharma AB | 209.14M |
| Alzinova AB | 206.69M |
| Abera Bioscience AB | 168.91M |
| Elicera Therapeutics AB | 166.51M |
| Biovica International AB | 160.55M |
| Diamyd Medical AB | 158.70M |
| Xintela AB | 156.32M |